Answer
Conventional intravenous doxorubicin hydrochloride has a terminal elimination half-life of 30 hours, reflecting distribution into a deep tissue compartment.
Sources for this answer
- Doxorubicin Solution for InjectionPfizer Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 12Document updated
Sources checked